Vitamin D Therapy Market by Age Group, Purchase Pattern and Application - Global Industry Analysis & Forecast to 2025

Published On : August 2019 Pages : 174 Category: Pharma & Healthcare Report Code : HC084855

Vitamin D Therapy Market By Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

Vitamin D is viewed as a gathering of fat-dissolvable secosteroids that guide in expanding the intestinal ingestion of calcium, phosphate, and magnesium. The significant Vitamin D mixes in people incorporate Vitamin D3 (known as cholecalciferol) and Vitamin D2 (known as ergocalciferol). Vitamin D insufficiency has been one of the normal issues in the previous couple of years inferable from less introduction to sun, ascribed to inactive ways of life. Manifestations of Vitamin D inadequacy incorporate muscle shortcoming and bone torment. Dietary Vitamin D is managed to treat the inadequacy.

Drivers and Restraints

The worldwide Vitamin D treatment market is driven by increment in the objective patient populace, ascend in mindfulness about nutrient D insufficiency, flood in levels of ailing health, increment in patient consistence to oral drugs, ascend in predominance of hypovitaminosis D, maturing populace, stationary ways of life, and absence of introduction to sun. Also, key acquisitions and joint endeavors among organizations add to the development of the market.

Regional Insights

North America commanded the worldwide market as far as income in 2018. The pattern is anticipated to keep during the figure time frame attributable to the nearness of driving players, center around innovative work, and increment in social insurance speculations by makers, and settled medicinal services foundation.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Abbott
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis International AG
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • Torrent Pharmaceuticals Ltd.
  • Alkem Laboratories
  • Cadila Healthcare Ltd

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Vitamin D Therapy Market, By Age Group, Estimates and Forecast, 2014-2025 ($Million)

o    Children

o    Adult

o    Senior Adult

·         Vitamin D Therapy Market, By Purchase Pattern, Estimates and Forecast, 2014-2025 ($Million)

o    OTC

o    Prescription

·         Vitamin D Therapy Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o    Osteoporosis

o    Rickets

o    Autoimmune Disorder

o    Skin Diseases

·         Vitamin D Therapy Market, By Key Players, Estimates and Forecast, 2014-2025 ($Million)

o    Abbott

o    GlaxoSmithKline plc

o    Merck & Co., Inc.

o    Novartis International AG

o    Sun Pharmaceutical Industries Ltd.

o    Sanofi

o    Pfizer Inc.

o    Torrent Pharmaceuticals Ltd.

o    Alkem Laboratories

o    Cadila Healthcare Ltd

·         Vitamin D Therapy Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o    North America

§  North America Vitamin D Therapy Market, By Country

o    U.S. Vitamin D Therapy Market

o    Canada Vitamin D Therapy Market

o    Mexico Vitamin D Therapy Market

o    Europe

§  Europe Vitamin D Therapy Market, By Country

·         Germany Vitamin D Therapy Market

o    UK Vitamin D Therapy Market

o    France Vitamin D Therapy Market

o    Russia Vitamin D Therapy Market

o    Italy Vitamin D Therapy Market

o    Rest of Europe Vitamin D Therapy Market

o    Asia-Pacific

§  Asia-Pacific Vitamin D Therapy Market, By Country

o    China Vitamin D Therapy Market

o    Japan Vitamin D Therapy Market

o    South Korea Vitamin D Therapy Market

o    India Vitamin D Therapy Market

o    Southeast Asia Vitamin D Therapy Market

o    Rest of Asia-Pacific Vitamin D Therapy Market

o    South America

§  South America Vitamin D Therapy Market

o    Brazil Vitamin D Therapy Market

o    Argentina Vitamin D Therapy Market

o    Columbia Vitamin D Therapy Market

o    Rest of South America Vitamin D Therapy Market

o    Middle East and Africa

§  Middle East and Africa Vitamin D Therapy Market

o    Saudi Arabia Vitamin D Therapy Market

o    UAE Vitamin D Therapy Market

o    Egypt Vitamin D Therapy Market

o    Nigeria Vitamin D Therapy Market

o    South Africa Vitamin D Therapy Market

o    Rest of MEA Vitamin D Therapy Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Vitamin D Therapy Market, By Age Group

5.1.     Introduction

5.2.     Global Vitamin D Therapy Revenue and Market Share by Age Group (2014-2018)

5.2.1.  Global Vitamin D Therapy Revenue and Revenue Share by Age Group (2014-2018)

5.3.     Children

5.3.1.  Global Children Revenue and Growth Rate (2014-2018)

5.4.     Adult

5.4.1.  Global Adult Revenue and Growth Rate (2014-2018)

5.5.     Senior Adult

5.5.1.  Global Senior Adult Revenue and Growth Rate (2014-2018)

6.       Vitamin D Therapy Market, By Purchase Pattern

6.1.     Introduction

6.2.     Global Vitamin D Therapy Revenue and Market Share by Purchase Pattern (2014-2018)

6.2.1.  Global Vitamin D Therapy Revenue and Revenue Share by Purchase Pattern (2014-2018)

6.3.     OTC

6.3.1.  Global OTC Revenue and Growth Rate (2014-2018)

6.4.     Prescription

6.4.1.  Global Prescription Revenue and Growth Rate (2014-2018)

7.       Vitamin D Therapy Market, By Application

7.1.     Introduction

7.2.     Global Vitamin D Therapy Revenue and Market Share by Application (2014-2018)

7.2.1.  Global Vitamin D Therapy Revenue and Revenue Share by Application (2014-2018)

7.3.     Osteoporosis

7.3.1.  Global Osteoporosis Revenue and Growth Rate (2014-2018)

7.4.     Rickets

7.4.1.  Global Rickets Revenue and Growth Rate (2014-2018)

7.5.     Autoimmune Disorder

7.5.1.  Global Autoimmune Disorder Revenue and Growth Rate (2014-2018)

7.6.     Skin Diseases

7.6.1.  Global Skin Diseases Revenue and Growth Rate (2014-2018)

8.       Vitamin D Therapy Market, By Region

8.1.     Introduction

8.2.     Global Vitamin D Therapy Revenue and Market Share by Regions

8.2.1.  Global Vitamin D Therapy Revenue by Regions (2014-2018)

8.3.     North America Vitamin D Therapy by Countries

8.3.1.  North America Vitamin D Therapy Revenue and Growth Rate (2014-2018)

8.3.2.  North America Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)

8.3.3.  United States

8.3.3.1.  United States Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.4.  Canada

8.3.4.1.  Canada Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.5.  Mexico

8.3.5.1.  Mexico Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.     Europe Vitamin D Therapy by Countries

8.4.1.  Europe Vitamin D Therapy Revenue and Growth Rate (2014-2018)

8.4.2.  Europe Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)

8.4.3.  Germany

8.4.3.1.  Germany Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.4.  France

8.4.4.1.  France Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.5.  UK

8.4.5.1.  UK Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  Russia

8.4.6.1.  Russia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  Italy

8.4.7.1.  Italy Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.     Asia-Pacific Vitamin D Therapy by Countries

8.5.1.  Asia-Pacific Vitamin D Therapy Revenue and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)

8.5.3.  China

8.5.3.1.  China Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.4.  Japan

8.5.4.1.  Japan Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.5.  Korea

8.5.5.1.  Korea Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  India

8.5.6.1.  India Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.     South America Vitamin D Therapy by Countries

8.6.1.  South America Vitamin D Therapy Revenue and Growth Rate (2014-2018)

8.6.2.  South America Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)

8.6.3.  Brazil

8.6.3.1.  Brazil Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.4.  Argentina

8.6.4.1.  Argentina Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.5.  Columbia

8.6.5.1.  Columbia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.     Middle East and Africa Vitamin D Therapy by Countries

8.7.1.  Middle East and Africa Vitamin D Therapy Revenue and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.5.  Egypt

8.7.5.1.  Egypt Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  South Africa

8.7.7.1.  South Africa Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Turkey

8.7.8.1.  Turkey Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.     Abbott

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.  Financial Overview

9.2.     GlaxoSmithKline plc

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.  Financial Overview

9.3.     Merck & Co., Inc.

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.  Financial Overview

9.4.     Novartis International AG

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.  Financial Overview

9.5.     Sun Pharmaceutical Industries Ltd.

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.  Financial Overview

9.6.     Sanofi

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.  Financial Overview

9.7.     Pfizer Inc.

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.  Financial Overview

9.8.     Torrent Pharmaceuticals Ltd.

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.  Financial Overview

9.9.     Alkem Laboratories

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.  Financial Overview

9.10. Cadila Healthcare Ltd

9.10.1.      Business Overview

9.10.2.       Service Portfolio

9.10.3.      Strategic Developments

9.10.4.      Financial Overview

10.    Vitamin D Therapy Market Forecast (2018-2025)

10.1. Global Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Vitamin D Therapy Market Forecast by Regions (2018-2025)

10.2.1.      North America Vitamin D Therapy Market Forecast (2018-2025)

10.2.1.1. United States Vitamin D Therapy Market Forecast (2018-2025)

10.2.1.2. Canada Vitamin D Therapy Market Forecast (2018-2025)

10.2.1.3. Mexico Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.      Europe Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.1. Germany Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.2. France Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.3. UK Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.4. Russia Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.5. Italy Vitamin D Therapy Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.1. China Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.2. Japan Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.3. Korea Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.4. India Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Vitamin D Therapy Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Vitamin D Therapy Market Forecast (2018-2025)

10.2.4.      South America Vitamin D Therapy Market Forecast (2018-2025)

10.2.4.1. Brazil Vitamin D Therapy Market Forecast (2018-2025)

10.2.4.2. Argentina Vitamin D Therapy Market Forecast (2018-2025)

10.2.4.3. Columbia Vitamin D Therapy Market Forecast (2018-2025)

10.2.4.4. Rest of South America Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.3. Egypt Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.4. Nigeria Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.5. South Africa Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.6. Turkey Vitamin D Therapy Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Vitamin D Therapy Market Forecast (2018-2025)

10.3. Vitamin D Therapy Market Forecast by Age Group (2018-2025)

10.3.1.      Vitamin D Therapy Forecast by Age Group (2018-2025)

10.3.2.      Vitamin D Therapy Market Share Forecast by Age Group (2018-2025)

10.4. Vitamin D Therapy Market Forecast by Purchase Pattern (2018-2025)

10.4.1.      Vitamin D Therapy Forecast by Purchase Pattern (2018-2025)

10.4.2.      Vitamin D Therapy Market Share Forecast by Purchase Pattern (2018-2025)

10.5. Vitamin D Therapy Market Forecast by Application (2018-2025)

10.5.1.      Vitamin D Therapy Forecast by Application (2018-2025)

10.5.2.      Vitamin D Therapy Market Share Forecast by Application (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Vitamin D Therapy Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Vitamin D Therapy Revenue and Revenue Share by Age Group (2014-2018)
Figure Global Children Revenue and Growth Rate (2014-2018)
Figure Global Adult Revenue and Growth Rate (2014-2018)
Figure Global Senior Adult Revenue and Growth Rate (2014-2018)
Table Global Vitamin D Therapy Revenue and Revenue Share by Purchase Pattern (2014-2018)
Figure Global OTC Revenue and Growth Rate (2014-2018)
Figure Global Prescription Revenue and Growth Rate (2014-2018)
Table Global Vitamin D Therapy Revenue and Revenue Share by Application (2014-2018)
Figure Global Osteoporosis Revenue and Growth Rate (2014-2018)
Figure Global Rickets Revenue and Growth Rate (2014-2018)
Figure Global Autoimmune Disorder Revenue and Growth Rate (2014-2018)
Figure Global Skin Diseases Revenue and Growth Rate (2014-2018)
Table Global Vitamin D Therapy Revenue by Regions (2014-2018)
Figure North America Vitamin D Therapy Growth Rate (2014-2018)
Figure North America Vitamin D Therapy Revenue and Growth Rate (2014-2018)
Figure North America Vitamin D Therapy by Countries (2014-2018)
Figure North America Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)
Figure United States Vitamin D Therapy Growth Rate (2014-2018)
Figure United States Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Vitamin D Therapy Growth Rate (2014-2018)
Figure Canada Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Vitamin D Therapy Growth Rate (2014-2018)
Figure Mexico Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Vitamin D Therapy Growth Rate (2014-2018)
Figure Europe Vitamin D Therapy Revenue and Growth Rate (2014-2018)
Figure Europe Vitamin D Therapy by Countries (2014-2018)
Figure Europe Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Germany Vitamin D Therapy Growth Rate (2014-2018)
Figure Germany Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Vitamin D Therapy Growth Rate (2014-2018)
Figure France Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Vitamin D Therapy Growth Rate (2014-2018)
Figure UK Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Vitamin D Therapy Growth Rate (2014-2018)
Figure Russia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Vitamin D Therapy Growth Rate (2014-2018)
Figure Italy Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Vitamin D Therapy Growth Rate (2014-2018)
Figure Rest of Europe Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Vitamin D Therapy Growth Rate (2014-2018)
Figure Asia-Pacific Vitamin D Therapy Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Vitamin D Therapy by Countries (2014-2018)
Figure Asia-Pacific Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)
Figure China Vitamin D Therapy Growth Rate (2014-2018)
Figure China Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Vitamin D Therapy Growth Rate (2014-2018)
Figure Japan Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Vitamin D Therapy Growth Rate (2014-2018)
Figure Korea Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Vitamin D Therapy Growth Rate (2014-2018)
Figure India Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Vitamin D Therapy Growth Rate (2014-2018)
Figure Southeast Asia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Vitamin D Therapy Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Vitamin D Therapy Growth Rate (2014-2018)
Figure South America Vitamin D Therapy Revenue and Growth Rate (2014-2018)
Figure South America Vitamin D Therapy by Countries (2014-2018)
Figure South America Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Vitamin D Therapy Growth Rate (2014-2018)
Figure Brazil Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Vitamin D Therapy Growth Rate (2014-2018)
Figure Argentina Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Vitamin D Therapy Growth Rate (2014-2018)
Figure Columbia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Vitamin D Therapy Growth Rate (2014-2018)
Figure Rest of South America Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Vitamin D Therapy Growth Rate (2014-2018)
Figure Middle East and Africa Vitamin D Therapy Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Vitamin D Therapy by Countries (2014-2018)
Figure Middle East and Africa Vitamin D Therapy Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Vitamin D Therapy Growth Rate (2014-2018)
Figure Saudi Arabia Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Vitamin D Therapy Growth Rate (2014-2018)
Figure United Arab Emirates Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Vitamin D Therapy Growth Rate (2014-2018)
Figure Egypt Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Vitamin D Therapy Growth Rate (2014-2018)
Figure Nigeria Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Vitamin D Therapy Growth Rate (2014-2018)
Figure South Africa Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Vitamin D Therapy Growth Rate (2014-2018)
Figure Turkey Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Vitamin D Therapy Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2014-2018)
Table Abbott Vitamin D Therapy Financial Overview
Table GlaxoSmithKline plc Vitamin D Therapy Financial Overview
Table Merck & Co., Inc. Vitamin D Therapy Financial Overview
Table Novartis International AG Vitamin D Therapy Financial Overview
Table Sun Pharmaceutical Industries Ltd. Vitamin D Therapy Financial Overview
Table Sanofi Vitamin D Therapy Financial Overview
Table Pfizer Inc. Vitamin D Therapy Financial Overview
Table Torrent Pharmaceuticals Ltd. Vitamin D Therapy Financial Overview
Table Alkem Laboratories Vitamin D Therapy Financial Overview
Table Cadila Healthcare Ltd Vitamin D Therapy Financial Overview
Figure Global Vitamin D Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Vitamin D Therapy Market Forecast by Regions (2018-2025)
Figure North America Vitamin D Therapy Market Forecast (2018-2025)
Figure United States Vitamin D Therapy Market Forecast (2018-2025)
Figure Canada Vitamin D Therapy Market Forecast (2018-2025)
Figure Mexico Vitamin D Therapy Market Forecast (2018-2025)
Figure Europe Vitamin D Therapy Market Forecast (2018-2025)
Figure Germany Vitamin D Therapy Market Forecast (2018-2025)
Figure France Vitamin D Therapy Market Forecast (2018-2025)
Figure UK Vitamin D Therapy Market Forecast (2018-2025)
Figure Russia Vitamin D Therapy Market Forecast (2018-2025)
Figure Italy Vitamin D Therapy Market Forecast (2018-2025)
Figure Rest of Europe Vitamin D Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Vitamin D Therapy Market Forecast (2018-2025)
Figure China Vitamin D Therapy Market Forecast (2018-2025)
Figure Japan Vitamin D Therapy Market Forecast (2018-2025)
Figure Korea Vitamin D Therapy Market Forecast (2018-2025)
Figure India Vitamin D Therapy Market Forecast (2018-2025)
Figure Southeast Asia Vitamin D Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Vitamin D Therapy Market Forecast (2018-2025)
Figure South America Vitamin D Therapy Market Forecast (2018-2025)
Figure Brazil Vitamin D Therapy Market Forecast (2018-2025)
Figure Argentina Vitamin D Therapy Market Forecast (2018-2025)
Figure Columbia Vitamin D Therapy Market Forecast (2018-2025)
Figure Rest of South America Vitamin D Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Vitamin D Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Vitamin D Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Vitamin D Therapy Market Forecast (2018-2025)
Figure Egypt Vitamin D Therapy Market Forecast (2018-2025)
Figure Nigeria Vitamin D Therapy Market Forecast (2018-2025)
Figure South Africa Vitamin D Therapy Market Forecast (2018-2025)
Figure Turkey Vitamin D Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Vitamin D Therapy Market Forecast (2018-2025)
Figure Global Vitamin D Therapy Forecast by Age Group (2018-2025)
Figure Global Vitamin D Therapy Market Share Forecast by Age Group (2018-2025)
Figure Global Vitamin D Therapy Forecast by Age Group (2018-2025)
Figure Global Vitamin D Therapy Forecast by Purchase Pattern (2018-2025)
Figure Global Vitamin D Therapy Market Share Forecast by Purchase Pattern (2018-2025)
Figure Global Vitamin D Therapy Forecast by Purchase Pattern (2018-2025)
Figure Global Vitamin D Therapy Forecast by Application (2018-2025)
Figure Global Vitamin D Therapy Market Share Forecast by Application (2018-2025)
Figure Global Vitamin D Therapy Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*